The neurofibromatosis type 1 gene encodes a protein related to GAP
Abstract
cDNA walking and sequencing have extended the open reading frame for the neurofibromatosis type 1 gene (NF1). The new sequence now predicts 2485 amino acids of the NF1 peptide. A 360 residue region of the new peptide shows significant similarity to the known catalytic domains of both human and bovine GAP (GTPase activating protein). A much broader region, centered around this same 360 amino acid sequence, is strikingly similar to the yeast IRA1 product, which has a similar amino acid sequence and functional homology to mammalian GAP. This evidence suggests that NF1 encodes a cytoplasmic GAP-like protein that may be involved in the control of cell growth by interacting with proteins such as the RAS gene product. Mapping of the cDNA clones has confirmed that NF1 spans a t(1;17) translocation mutation and that three active genes lie within an intron of NF1, but in opposite orientation.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
KRAS proteins primarily bind GDP and are in an inactive conformation maintained by intrinsic GTP hydrolytic activity.
“KRAS proteins primarily bind to guanosine diphosphate (GDP) and are in an inactive conformation maintained by intrinsic guanosine triphosphate (GTP) hydrolytic activity.”
From Targeting KRAS mutant cancers: from druggable therapy to drug resistance (2022) · cites this paper as [9]
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572 · see citing works
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,512 · see citing works
A simple method for displaying the hydropathic character of a protein
Kyte, J., & Doolittle, R. F. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90515-0 · Cited by 22,694 · see citing works
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P. E., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222 · see citing works
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227 · see citing works
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
(1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90381-6 · Cited by 4,950 · see citing works
Screening λgt Recombinant Clones by Hybridization to Single Plaques in Situ
Benton, W. D., & Davis, R. W. (1977) · Science · doi:10.1126/science.322279 · Cited by 4,660 · see citing works
Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs
Kozak, M. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.2.857 · Cited by 3,293 · see citing works
[5] Rapid and sensitive sequence comparison with FASTP and FASTA
Pearson, W. R. (1990) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(90)83007-v · Cited by 1,934 · see citing works
Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 Patients
Wallace, M. R., Marchuk, D. A., Andersen, L. B., Letcher, R., Odeh, H. M., Saulino, A. M., Fountain, J. W., Brereton, A., Nicholson, J. M., Mitchell, A. L., et al. (1990) · Science · doi:10.1126/science.2134734 · Cited by 1,476 · see citing works
Neurofibromatosis. Conference statement, National Institute of Health development conference
Stumpf, D. A. (1988) · JAMA Neurology · Cited by 1,234 · see citing works
Trahey, M., & McCormick, F. (1987) · Science · doi:10.1126/science.2821624 · Cited by 1,211 · see citing works
In yeast, RAS proteins are controlling elements of adenylate cyclase
Toda, T., Uno, I., Ishikawa, T., Powers, S., Kataoka, T., Broek, D., Cameron, S., Broach, J. R., Matsumoto, K., & Wigler, M. H. (1985) · Cell · doi:10.1016/0092-8674(85)90305-8 · Cited by 1,108 · see citing works
Cawthon, R., Weiss, R. B., Xu, G., Viskochil, D. H., Culver, M., Stevens, J., Robertson, M. A., Dunn, D. M., Gesteland, R. F., O'Connell, P., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90253-b · Cited by 1,093 · see citing works
Self-citationDeletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
Viskochil, D. H., Buchberg, A. M., Xu, G., Cawthon, R., Stevens, J., Wolff, R. K., Culver, M., Carey, J. C., Copeland, N. G., Jenkins, N. A., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90252-a · Cited by 1,082 · see citing works
Self-citationA ras-related gene with transformation suppressor activity
Kitayama, H., Sugimoto, Y., Matsuzaki, T., Ikawa, Y., & Noda, M. (1989) · Cell · doi:10.1016/0092-8674(89)90985-9 · Cited by 942 · see citing works
Neurofibromatosis, Phenotype, Natural History, and Pathogenesis
Riccardi, V. M., & Smirniotopoulos, J. G. (1992) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199211000-00009 · Cited by 789 · see citing works
Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases
Ellis, C. A., Moran, M. F., McCormick, F. P., & Pawson, T. J. (1990) · Nature · doi:10.1038/343377a0 · Cited by 746 · see citing works
Kaplan, D. R., Morrison, D. K., Wong, G. A., McCormick, F. P., & Williams, L. T. (1990) · Cell · doi:10.1016/0092-8674(90)90220-9 · Cited by 519 · see citing works
Guanosine Triphosphatase Activating Protein (GAP) Interacts with the p21 ras Effector Binding Domain
Adari, H. Y., Lowy, D. R., Willumsen, B. M., Der, C. J., & McCormick, F. P. (1988) · Science · doi:10.1126/science.2833817 · Cited by 506 · see citing works
Molecular Cloning of Two Types of GAP Complementary DNA from Human Placenta
Trahey, M., Wong, G. A., Halenbeck, R., Rubinfeld, B., Martin, G. A., Ladner, M. B., Long, C. M., Crosier, W. J., Watt, K., Koths, K. E., et al. (1988) · Science · doi:10.1126/science.3201259 · Cited by 468 · see citing works
The cytoplasmic protein GAP is implicated as the target for regulation by the ras gene product
Calés, C., Hancock, J. F., Marshall, C. J., & Hall, A. (1988) · Nature · doi:10.1038/332548a0 · Cited by 386 · see citing works
Mutation and childhood cancer: a probabilistic model for the incidence of retinoblastoma.
Knudson, A. G., Hethcote, H. W., & Brown, B. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.12.5116 · Cited by 351 · see citing works
Tanaka, K., Nakafuku, M., Satoh, T., Marshall, M. S., Gibbs, W. W., Matsumoto, K., Kaziro, Y., & Toh‐e, A. (1990) · Cell · doi:10.1016/0092-8674(90)90094-u · Cited by 323 · see citing works
Tanaka, K., Nakafuku, M., Tamanoi, F., Kaziro, Y., Matsumoto, K., & Toh‐e, A. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.8.4303 · Cited by 292 · see citing works
Inhibition of GTPase Activating Protein Stimulation of Ras-p21 GTPase by the K rev -1 Gene Product
Frech, M., John, J., Pizon, V., Chardin, P., Tavitian, A., Clark, R., McCormick, F. P., & Wittinghofer, A. (1990) · Science · doi:10.1126/science.2164710 · Cited by 251 · see citing works
IRA1, an inhibitory regulator of the RAS-cyclic AMP pathway in Saccharomyces cerevisiae.
Tanaka, K., Matsumoto, K., & Toh‐e, A. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.2.757 · Cited by 245 · see citing works
Feramisco, J. R., Glass, D. B., & Krebs, E. G. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85658-2 · Cited by 223 · see citing works
A transcribed gene in an intron of the human factor VIII gene
Levinson, B., Kenwrick, S. J., Lakich, D., Hammonds, R. G., & Gitschier, J. M. (1990) · Genomics · doi:10.1016/0888-7543(90)90512-s · Cited by 181 · see citing works
ras and GAP—Who's controlling whom?
Hall, A. (1990) · Cell · doi:10.1016/0092-8674(90)90054-i · Cited by 180 · see citing works
A C‐terminal domain of GAP is sufficient to stimulate ras p21 GTPase activity.
Marshall, M. S., Hill, W. S., Ng, A. S., Vogel, U. S., Schaber, M. D., Scolnick, E. M., Dixon, R. A., Sigal, I. S., & Gibbs, W. W. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03480.x · Cited by 159 · see citing works
Mikol, D. D., Gulcher, J. R., & Stefánsson, K. (1990) · The Journal of Cell Biology · doi:10.1083/jcb.110.2.471 · Cited by 150 · see citing works
Genetic analysis of mammalian GAP expressed in yeast
Ballester, R., Michaeli, T., Ferguson, K. M., Xu, H., McCormick, F. P., & Wigler, M. H. (1989) · Cell · doi:10.1016/0092-8674(89)90014-7 · Cited by 133 · see citing works
Regional mapping panel for human chromosome 17: Application to neurofibromatosis type 1
van Tuinen, P., Rich, D. C., SUMMERS, K. M., & Ledbetter, D. H. (1987) · Genomics · doi:10.1016/0888-7543(87)90042-5 · Cited by 119 · see citing works
Neurofibromatosis: Phenotype, Natural History and Pathogenesis
Huson, S. M. (1987) · Journal of Medical Genetics · doi:10.1136/jmg.24.9.574 · Cited by 93 · see citing works
Cases of neurofibromatosis with rearrangements of chromosome 17 involving band 17q11.2
Schmidt, M. A., Michels, V. V., Dewald, G. W., Opitz, J. M., & Reynolds, J. F. (1987) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320280333 · Cited by 87 · see citing works
O'Connell, P., Viskochil, D. H., Buchberg, A. M., Fountain, J. W., Cawthon, R., Culver, M., Stevens, J., Rich, D. C., Ledbetter, D. H., Wallace, M. R., et al. (1990) · Genomics · doi:10.1016/0888-7543(90)90198-4 · Cited by 74 · see citing works
Self-citationMENON, A. (1989) · Genomics · doi:10.1016/0888-7543(89)90053-0 · Cited by 66 · see citing works
Enzymatic amplification of specific cDNA inserts from λgt11 libraries
Friedman, K. D., Rosen, N. L., Newman, P. J., & Montgomery, R. R. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.17.8718 · Cited by 52 · see citing works
Tightly linked markers for the neurofibromatosis type 1 gene
White, R. L., Nakamura, Y., O'Connell, P., Leppert, M., Lalouel, J.-M., Barker, D. F., Goldgar, D. E., Skolnick, M. H., Carey, J. C., Wallis, C., et al. (1987) · Genomics · doi:10.1016/0888-7543(87)90040-1 · Cited by 38 · see citing works
Self-citationRecent changes in the GenBank®On-line Service
Benton, D. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.6.1517 · Cited by 37 · see citing works
Hsieh, C., Vogel, U. S., Dixon, R. A. F., & Francke, U. (1989) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01534919 · Cited by 34 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Oncogenes and signal transduction
Cantley, L. C., Auger, K. R., Carpenter, C. F., Duckworth, B. C., Graziani, A., Kapeller, R., & Soltoff, S. P. (1991) · Cell · doi:10.1016/0092-8674(91)90639-g · Cited by 2,697 · see citing works
The GTPase superfamily: a conserved switch for diverse cell functions
Bourne, H. R., Sanders, D. A. R., & McCormick, F. P. (1990) · Nature · doi:10.1038/348125a0 · Cited by 2,336 · see citing works
Mammalian Ras interacts directly with the serine/threonine kinase Raf.
Vojtek, A., Hollenberg, S., & Cooper, J. A. (1993) · Cell · doi:10.1016/0092-8674(93)90307-c · Cited by 1,971 · see citing works
RAS oncogenes: the first 30 years
Malumbres, M., & Barbacid, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1097 · Cited by 1,902 · see citing works
SH2 and SH3 Domains: Elements that Control Interactions of Cytoplasmic Signaling Proteins
Koch, C. A., Anderson, D. H., Moran, M. F., Ellis, C. A., & Pawson, T. J. (1991) · Science · doi:10.1126/science.1708916 · Cited by 1,868 · see citing works
Weinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,765 · see citing works
Molecular themes in oncogenesis
Bishop, J. M. (1991) · Cell · doi:10.1016/0092-8674(91)90636-d · Cited by 1,619 · see citing works
The Ras-RasGAP Complex: Structural Basis for GTPase Activation and Its Loss in Oncogenic Ras Mutants
Scheffzek, K., Ahmadian, M. R., Kabsch, W., Wiesmüller, L., Lautwein, A., Schmitz, F., & Wittinghofer, A. (1997) · Science · doi:10.1126/science.277.5324.333 · Cited by 1,543 · see citing works
Hyperactive Ras in developmental disorders and cancer
Schubbert, S., Shannon, K., & Bollag, G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2109 · Cited by 1,583 · see citing works
Ras oncogenes: split personalities
Karnoub, A. E., & Weinberg, R. A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2438 · Cited by 1,467 · see citing works
“Soon thereafter, the second RasGAP, neurofibromin-1 ( NF1 ), was identified and found to be disrupted in patients with neurofibromatosi”
Identification and characterization of the tuberous sclerosis gene on chromosome 16
(1993) · Cell · doi:10.1016/0092-8674(93)90618-z · Cited by 1,645 · see citing works
Trofatter, J. A. (1993) · Cell · doi:10.1016/0092-8674(93)90406-g · Cited by 1,390 · see citing works
RAS-targeted therapies: is the undruggable drugged?
Moore, A. R., Rosenberg, S. C., McCormick, F., & Malek, S. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0068-6 · Cited by 1,103 · see citing works
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
Ferner, R. E., Huson, S., Thomas, N., Moss, C., Willshaw, H., Evans, D. G., Upadhyaya, M., Towers, R., Gleeson, M. J., Steiger, C., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.045906 · Cited by 1,049 · see citing works
The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21
Martin, G. A., Viskoohil, D., Bollag, G. E., McCabe, P. C., Crosier, W. J., Haubruck, H., Conroy, L., Clark, R., O'Connell, P., Cawthon, R., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90150-d · Cited by 983 · see citing works
Self-citationWoods, D. F., & Bryant, P. J. (1991) · Cell · doi:10.1016/0092-8674(81)90009-x · Cited by 898 · see citing works
The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins.
Ballester, R., Marchuk, D., Boguski, M., Saulino, A., Letcher, R., Wigler, M., & Collins, F. (1990) · Cell · doi:10.1016/0092-8674(90)90151-4 · Cited by 847 · see citing works
“Under our assay conditions, NF1 lysates have less activity than lysates from cells expressing GAP Discussion The NFl locus encodes a protein that is structurally related to the IRA proteins of yeast and to the GAP protein of mammalian cells (Xu et al., 1990; Buchberg et al., 1990).”
BackgroundMethodResultInfluentialHuman RAS Superfamily Proteins and Related GTPases
Colicelli, J. (2004) · Science s STKE · doi:10.1126/stke.2502004re13 · Cited by 828 · see citing works
Tumour predisposition in mice heterozygous for a targeted mutation in Nf1
Jacks, T., Shih, T. S., Schmitt, E. M., Bronson, R. T., Bernards, A., & Weinberg, R. A. (1994) · Nature Genetics · doi:10.1038/ng0794-353 · Cited by 780 · see citing works
Antioncogenes and human cancer.
Knudson, A. G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.10914 · Cited by 770 · see citing works
Marshall, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90641-b · Cited by 752 · see citing works
The genomic landscape of hypodiploid acute lymphoblastic leukemia
Holmfeldt, L., Wei, L., Díaz-Flores, E., Walsh, M. F., Zhang, J., Ding, L., Payne-Turner, D., Churchman, M. L., Andersson, A., Chen, S.-C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2532 · Cited by 722 · see citing works
Xu, G., Lin, B. K., Tanaka, K., Dunn, D. M., Wood, D. R., Gesteland, R. F., White, R. L., Weiss, R. B., & Tamanoi, F. (1990) · Cell · doi:10.1016/0092-8674(90)90149-9 · Cited by 681 · see citing works
Self-citationAberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients
Basu, T. N., Gutmann, D. H., Fletcher, J. A., Glover, T. W., Collins, F. S., & Downward, J. (1992) · Nature · doi:10.1038/356713a0 · Cited by 669 · see citing works
Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design
Ostrem, J. M. L., & Shokat, K. M. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.139 · Cited by 641 · see citing works
Armstrong, E. J., & Bischoff, J. E. (2004) · Circulation Research · doi:10.1161/01.res.0000141146.95728.da · Cited by 648 · see citing works
Brannan, C. I., Perkins, A. S., Vogel, K. S., Ratner, N., Nordlund, M. L., Reid, S. W., Buchberg, A. M., Jenkins, N. A., Parada, L. F., & Copeland, N. G. (1994) · Genes & Development · doi:10.1101/gad.8.9.1019 · Cited by 641 · see citing works
Zhu, Y., Romero‐Ortega, M. I., Ghosh, P., Ye, Z., Charnay, P., Rushing, E. J., Marth, J. D., & Parada, L. F. (2001) · Genes & Development · doi:10.1101/gad.862101 · Cited by 606 · see citing works
“Loss of heterozygosity (LOH) at the NF1 locus has been identified in pheochromocytomas (Xu et al. 1992), neurofibrosarcomas (Legius et al. 1993), and myeloid leukemias (Side et al. 1997).”
BackgroundNF1 Tumor Suppressor Gene Function
Cichowski, K. M., & Jacks, T. (2001) · Cell · doi:10.1016/s0092-8674(01)00245-8 · Cited by 603 · see citing works
International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis.
Ferner, R. E., & Gutmann, D. H. (2002) · PubMed · Cited by 603 · see citing works
DeClue, J. E., Papageorge, A. G., Fletcher, J. A., Diehl, S. R., Ratner, N., Vass, W. C., & Lowy, D. R. (1992) · Cell · doi:10.1016/0092-8674(92)90407-4 · Cited by 580 · see citing works
Optic pathway gliomas in neurofibromatosis‐1: Controversies and recommendations
Listernick, R., Ferner, R. E., Liu, G. T., & Gutmann, D. H. (2007) · Annals of Neurology · doi:10.1002/ana.21107 · Cited by 574 · see citing works
Highly parallel identification of essential genes in cancer cells
Luo, B., Cheung, H. W., Subramanian, A., Sharifnia, T., Okamoto, M., Yang, X., Hinkle, G., Boehm, J. S., Beroukhim, R., Weir, B. A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810485105 · Cited by 541 · see citing works
Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective
Ferner, R. E. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70075-3 · Cited by 511 · see citing works
A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor
Ratner, N., & Miller, S. J. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3911 · Cited by 488 · see citing works
Jensen, R. T., Berna, M. J., Bingham, D. B., & Norton, J. A. (2008) · Cancer · doi:10.1002/cncr.23648 · Cited by 487 · see citing works
Boyd, K. P., Korf, B. R., & Theos, A. J. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.12.051 · Cited by 486 · see citing works
Cortical Actin Organization: Lessons from ERM (Ezrin/Radixin/Moesin) Proteins
Tsukita, S., & Yonemura, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34507 · Cited by 470 · see citing works
Listernick, R., Louis, D. N., Packer, R. J., & Gutmann, D. H. (1997) · Annals of Neurology · doi:10.1002/ana.410410204 · Cited by 469 · see citing works
Amino acids and mTORC1: from lysosomes to disease
Efeyan, A., Zoncu, R., & Sabatini, D. M. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.05.007 · Cited by 436 · see citing works
Neurofibromin Regulation of ERK Signaling Modulates GABA Release and Learning
Cui, Y., Costa, R. M., Murphy, G. G., Elgersma, Y., Zhu, Y., Gutmann, D. H., Parada, L. F., Módy, I., & Silva, A. J. (2008) · Cell · doi:10.1016/j.cell.2008.09.060 · Cited by 434 · see citing works
“Neurofibromin, a Ras GPTase-activating protein (RasGAP) encoded by the neurofibromatosis type I (NF1) gene (Martin et al., 1990; Xu et al., 1990), is thought to modulate Ras/ERK signaling, LTP, and learning in mice (Costa et al.”
Shannon, K., O'Connell, P., Martin, G. A., Paderanga, D., Olson, K., Dinndorf, P. A., & McCormick, F. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300903 · Cited by 440 · see citing works
Self-citationDistinctive Cancer Associations in Patients With Neurofibromatosis Type 1
Uusitalo, E., Rantanen, M. E., Kallionpää, R. A., Pöyhönen, M., Leppävirta, J., Ylä‐Outinen, H., Riccardi, V. M., Pukkala, ., Pitkäniemi, J. M., Peltonen, S. A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.3576 · Cited by 423 · see citing works
Somatic mutations in the neurofibromatosis 1 gene in human tumors
Li, Y., Bollag, G. E., Clark, R., Stevens, J., Conroy, L., Fults, D., Ward, K., Friedman, E., Samowitz, W. S., Robertson, M. A., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90408-5 · Cited by 394 · see citing works
Self-citationcDNA cloning of the type 1 neurofibromatosis gene: Complete sequence of the NF1 gene product
Marchuk, D. A., Saulino, A. M., Tavakkol, R., Swaroop, M., Wallace, M. R., Andersen, L. B., Mitchell, A. L., Gutmann, D. H., Boguski, M. S., & Collins, F. S. (1991) · Genomics · doi:10.1016/0888-7543(91)90017-9 · Cited by 390 · see citing works
Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis
Woodruff, J. M. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990326)89:1 · Cited by 229 · see citing works
Requirement for a GTPase-Activating Protein in Vesicle Budding from the Endoplasmic Reticulum
Yoshihisa, T., Barlowe, C. K., & Schekman, R. W. (1993) · Science · doi:10.1126/science.8451644 · Cited by 384 · see citing works
Deletion of IRF-1 , Mapping to Chromosome 5q31.1, in Human Leukemia and Preleukemic Myelodysplasia
Willman, C. L., Sever, C. E., Pallavicini, M. G., Harada, H., Tanaka, N., Slovak, M. L., Yamamoto, H., Harada, K., Meeker, T. C., List, A. F., et al. (1993) · Science · doi:10.1126/science.8438156 · Cited by 380 · see citing works
Confirmation of the arginine-finger hypothesis for the GAP-stimulated GTP-hydrolysis reaction of Ras
Ahmadian, M. R., Stege, P., Scheffzek, K., & Wittinghofer, A. (1997) · Nature Structural Biology · doi:10.1038/nsb0997-686 · Cited by 370 · see citing works
Mouse Tumor Model for Neurofibromatosis Type 1
Vogel, K. S., Klesse, L. J., Velasco-Miguel, S., Meyers, K. A., Rushing, E. J., & Parada, L. F. (1999) · Science · doi:10.1126/science.286.5447.2176 · Cited by 372 · see citing works
Molecular genetics of neurofibromatosis type 1 (NF1).
Shen, M. H., Harper, P. S., & Upadhyaya, M. (1996) · Journal of Medical Genetics · doi:10.1136/jmg.33.1.2 · Cited by 371 · see citing works
GAPs galore! A survey of putative Ras superfamily GTPase activating proteins in man and Drosophila
Bernards, A. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00082-3 · Cited by 362 · see citing works
A Comprehensive Genetic Linkage Map of the Human Genome
NIH/CEPH Collaborative Mapping Group (1992) · Science · doi:10.1126/science.1439770 · Cited by 358 · see citing works
Kim, D. H., Murovic, J. A., Tiel, R. L., Moes, G., & Kline, D. G. (2005) · Journal of neurosurgery · doi:10.3171/jns.2005.102.2.0246 · Cited by 342 · see citing works
GENE DISCOVERY INDROSOPHILA: New Insights for Learning and Memory
Dubnau, J., & Tully, T. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.407 · Cited by 336 · see citing works
“In mammals,NF1 is believed to function as a GTPase-activating protein for Ras (Ras-GAP) and therefore as a negative regulator of Ras (Ballester et al 1990; Buckberg et al 1990; Martin et al 1990; Xu et al 1990a,b).”
BackgroundMalignancy in Neurofibromatosis Type 1
Korf, B. R. (2000) · The Oncologist · doi:10.1634/theoncologist.5-6-477 · Cited by 328 · see citing works
Dohlman, H. G., Song, J., Ma, D., Courchesne, W. E., & Thorner, J. W. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.5194 · Cited by 323 · see citing works
“Both GAP and NF-1 stimulate in vitro GTP hydrolysis by the low-molecular-weight G-protein p21ras (71, 118).”
BackgroundInfluentialJones, P. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205597 · Cited by 321 · see citing works
Daston, M. M., Scrable, H. J., Nordlund, M. L., Sturbaum, A. K., Nissen, L. M., & Ratner, N. (1992) · Neuron · doi:10.1016/0896-6273(92)90270-n · Cited by 314 · see citing works
Fahsold, R., Hoffmeyer, S., Mischung, C., Gille, C., Ehlers, C., Kücükceylan, N., Abdel-Nour, M., Gewies, A., Hartmut Peters, A., Kaufmann, D., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/302809 · Cited by 313 · see citing works
“A central region of about 360 amino acids shows significant homology to the mammalian GTPase-activating protein (GAP) (Xu et al. 1990).”
BackgroundInfluentialDasgupta, B., Yi, Y., Chen, D. Y., Weber, J. D., & Gutmann, D. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4058 · Cited by 308 · see citing works
“Previous studies have shown that the NF1 gene encodes a protein termed neurofibromin, which contains a small domain with sequence similarity to a family of proteins that function to inhibit RAS activation (4).”
BackgroundAndersson‐Assarsson, J. C., Sihto, H. J., Meis‐Kindblom, J. M., Joensuu, H., Nupponen, N. N., & Kindblom, L. (2005) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000159775.77912.15 · Cited by 302 · see citing works
“2, encodes neurofibromin, which is a member of the GTPase activating protein (GAP) family of the RAS regulatory proteins.(46) Neurofibromin stimulates GTPase activity and negatively regulates RAS by catalyzing the conversion of the active GTP-bound RAS to its inactive GDP-bound form.”
BackgroundRegulators And Effectors Of Ras Proteins
Bollag, G. E., & McCormick, F. P. (1991) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.07.110191.003125 · Cited by 302 · see citing works
Reuter, C. W., Morgan, M. A., & Bergmann, L. (2000) · Blood · doi:10.1182/blood.v96.5.1655 · Cited by 300 · see citing works
Side, L. E., Taylor, B. R., Cayouette, M. C., Conner, E. R., Thompson, P., Luce, M. C., & Shannon, K. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706123362404 · Cited by 294 · see citing works
How many genes in the human genome?
Fields, C., Adams, M. D., White, O. R., & Venter, J. C. (1994) · Nature Genetics · doi:10.1038/ng0794-345 · Cited by 291 · see citing works
Gideon, P., John, J., Frech, M., Lautwein, A., Clark, R., Scheffler, J. E., & Wittinghofer, A. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.5.2050 · Cited by 287 · see citing works
Ferner, R. E., Golding, J. F., Smith, M. A., Calonje, E. J., Jan, W., Sanjayanathan, V., & O'Doherty, M. J. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm450 · Cited by 283 · see citing works
“Neurofibromin, the NF1 gene product, acts as a tumour suppressor by promoting the inactivation of the proto-oncogene p21RAS and by controlling the mammalian target of rapamycin [2, 3].”
RASA1: variable phenotype with capillary and arteriovenous malformations
Boon, L. M., Mulliken, J. B., & Vikkula, M. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.03.004 · Cited by 282 · see citing works
“RASA1 belongs to a family of four homologous proteins: RASA1, RASA2 (GAPM1), NF1 (neurofibromin) and RASAL (GAP1-like protein) [25–28].”
BackgroundInsulin stimulation of gene expression mediated by p21ras activation.
Burgering, B. M. T., Medema, R. H., Maassen, J. A., van de Wetering, M., van der Eb, A. J., McCormick, F. P., & Bos, J. L. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb08050.x · Cited by 280 · see citing works
Identification of the neurofibromatosis type 1 gene product.
Gutmann, D. H., Wood, D., & Collins, F. S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9658 · Cited by 279 · see citing works
Gaul, U., Mardon, G., & Rubin, G. M. (1992) · Cell · doi:10.1016/0092-8674(92)90073-l · Cited by 278 · see citing works
Yamauchi, T., Tada, M., Houkin, K., Tanaka, T., Nakamura, Y., Kuroda, S., Abe, H., Inoue, T. K., 池崎, 清., Matsushima, T., et al. (2000) · Stroke · doi:10.1161/01.str.31.4.930 · Cited by 276 · see citing works
Moran, M. F., Polakis, P. G., McCormick, F. P., Pawson, T. J., & Ellis, C. A. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.4.1804 · Cited by 266 · see citing works
Mammalian target of rapamycin complex 1: Signalling inputs, substrates and feedback mechanisms
Dunlop, E. A., & Tee, A. R. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.01.012 · Cited by 257 · see citing works
Rescue of a Drosophila NF1 Mutant Phenotype by Protein Kinase A
The, I., Hannigan, G. E., Cowley, G. S., Reginald, S., Zhong, Y., Gusella, J. F., Hariharan, I. K., & Bernards, A. (1997) · Science · doi:10.1126/science.276.5313.791 · Cited by 257 · see citing works
Serra, E. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.20.3055 · Cited by 254 · see citing works
Nuell, M. J., Stewart, D. A., Walker, L., Friedman, V., Wood, C. M., Owens, G. A., Smith, J. R., Schneider, E. L., Orco, R. D., Lumpkin, C. K., et al. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.3.1372 · Cited by 246 · see citing works
Neurofibromatosis and early onset of cancers in hMLH1-deficient children.
Wang, Q., Lasset, C., Desseigne, F., Frappaz, D., Bergeron, C., Navarro, C., Ruano, E., & Puisieux, A. (1999) · PubMed · Cited by 246 · see citing works
Molecular pathways in the formation of gliomas
von Deimling, A., Louis, D. N., & Wiestler, O. D. (1995) · Glia · doi:10.1002/glia.440150312 · Cited by 245 · see citing works
Confirmation of a Double-Hit Model for the NF1Gene in Benign Neurofibromas
Serra, E., Puig, S., Otero, D., Gaona, A., Kruyer, H., Ars, E., Estivill, X., & Lázaro, C. (1997) · The American Journal of Human Genetics · doi:10.1086/515504 · Cited by 241 · see citing works
Chemoprevention strategies for the control of cancer
Lippman, S. M., Benner, S. E., & Hong, W. K. (1993) · Cancer · doi:10.1002/1097-0142(19930801)72:3+ · Cited by 41 · see citing works
Ridley, A. J., Self, A. J., Kasmi, F., Paterson, H. F., Hall, A., Marshall, C. J., & Ellis, C. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06210.x · Cited by 238 · see citing works
Genomic organization of the neurofibromatosis 1 gene (NF1)
Li, Y., O'Connell, P., Breidenbach, H. H., Cawthon, R., Stevens, J., Xu, G., Neil, S. M., Robertson, M. A., White, R. L., & Viskochil, D. H. (1995) · Genomics · doi:10.1016/0888-7543(95)80104-t · Cited by 236 · see citing works
Self-citationIdentification of a human rasGAP-related protein containing calmodulin-binding motifs.
Weissbach, L., Settleman, J. E., Kalady, M. F., Snijders, A. J., Murthy, A. E., Yan, Y. X., & Bernards, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32023-9 · Cited by 235 · see citing works
Plasticity and injury in the developing brain
Johnston, M. V., Ishida, A., Nakajima, W., Matsushita, H., Nishimura, A., & Tsuji, M. (2008) · Brain and Development · doi:10.1016/j.braindev.2008.03.014 · Cited by 230 · see citing works
“For example, neurofibromatosis type 1 (NF-1) is caused by a mutation in the tumor suppressor gene for the protein neurofibromin, which is a GTPase activating protein (GAP) [25].”
Neurofibromatosis type 1 (NF1)
Ferner, R. E., & Gutmann, D. H. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52902-2.00053-9 · Cited by 230 · see citing works
“conversion of the Ras proto-oncogene from its active, GTP-bound to its inactive GDP-bound form (Xu et al., 1990).”
Targeting KRAS mutant cancers: from druggable therapy to drug resistance
Zhu, C., Guan, X., Zhang, X., Luan, X., Song, Z., Cheng, X., Zhang, W., & Qin, J.-J. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01629-2 · Cited by 231 · see citing works
Campagnoni, A. T., Pribyl, T. M., Campagnoni, C. W., Kampf, K., Amur-Umarjee, S. G., Landry, C. F., Handley, V., Newman, S. L., Garbay, B., & KITAMURA, K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53485-2 · Cited by 224 · see citing works
Cooperating oncogenes converge to regulate cyclin/cdk complexes.Preprint
Lloyd, A. C., Obermüller, F., Staddon, S., Barth, C. F., McMahon, M., & Land, H. (1997) · Genes & Development · doi:10.1101/gad.11.5.663 · Cited by 224 · see citing works
The NF1 gene in tumor syndromes and melanoma
Kiuru, M. H., & BUSAM, K. J. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2016.142 · Cited by 218 · see citing works
GTPase activating proteins: critical regulators of intracellular signaling
Donovan, S., Shannon, K., & Bollag, G. E. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00041-5 · Cited by 215 · see citing works
Identification and characterization of the neurofibromatosis type 1 protein product.
DeClue, J. E., Cohen, B. D., & Lowy, D. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.9914 · Cited by 215 · see citing works
Neurocristopathies: New insights 150 years after the neural crest discovery
Vega‐López, G. A., Cerrizuela, S., Tríbulo, C., & Aybar, M. J. (2018) · Developmental Biology · doi:10.1016/j.ydbio.2018.05.013 · Cited by 202 · see citing works
A Comprehensive Genetic Linkage Map of the Human Genome
Donis-Keller, H. (1992) · Science · Cited by 210 · see citing works
Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients.
Kayes, L. M., Burke, W., Riccardi, V. M., Bennett, R. L., Ehrlich, P., Rubenstein, A. E., & Stephens, K. G. (1994) · PubMed Central · Cited by 209 · see citing works
Requirement of Drosophila NF1 for Activation of Adenylyl Cyclase by PACAP38-Like Neuropeptides
Guo, H.-F., The, I., Hannan, F., Bernards, A., & Zhong, Y. (1997) · Science · doi:10.1126/science.276.5313.795 · Cited by 209 · see citing works
Side, L. E., Emanuel, P. D., Taylor, B. R., Franklin, J. L., Thompson, P., Castleberry, R. P., & Shannon, K. (1998) · Blood · doi:10.1182/blood.v92.1.267.413a31_267_272 · Cited by 206 · see citing works
Tumor microenvironment and neurofibromatosis type I: connecting the GAPs
Le, L. Q., & Parada, L. F. (2007) · Oncogene · doi:10.1038/sj.onc.1210261 · Cited by 205 · see citing works
“2 and was identified by positional cloning in 1990 (Ballester et al., 1990; Xu et al., 1990).”
The N‐terminal region of GAP regulates cytoskeletal structure and cell adhesion.
McGlade, J. C., Brunkhorst, B. A., Anderson, D. M., Mbamalu, G., Settleman, J. E., Dedhar, S., Rozakis-Adcock, M., Chen, L. B., & Pawson, T. J. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05976.x · Cited by 202 · see citing works
- Authors
- Xu, G., O'Connell, P., Viskochil, D., Cawthon, R., Robertson, M., Culver, M., Dunn, D., Stevens, J., Gesteland, R., White, R., & Weiss, R.
- Affiliations
- Howard Hughes Medical Institute (US)
- University of Utah (US)
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1990-08
- Volume
- 62
- Issue
- 3
- Pages
- 599-608
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2159096148
- Cited by
- 1,095
- References
- 42
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 19 · 2023: 19 · 2022: 22 · 2021: 22 · 2020: 22 · 2019: 18 · 2018: 22 · 2017: 17 · 2016: 19 · 2015: 21 · 2014: 24 · 2013: 24 · 2012: 45
- FWCI
- 70.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- U.S. Department of Energy
- Topics
- Health Sciences › Medicine › Neurology › Neurofibromatosis and Schwannoma Cases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- neurofibromatosis type 1, NF1 gene, GTPase-activating protein, Ras, open reading frames, cDNA cloning, cell growth regulation, protein homology
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cattle, Chromosomes, Human, Pair 1, Chromosomes, Human, Pair 17, Cloning, Molecular, Genes, Humans, Information Systems, Molecular Sequence Data, Neurofibromatosis 1, Proteins, Sequence Homology, Nucleic Acid, Translocation, Genetic, Oligonucleotide Probes, Gene Library, Polymerase Chain Reaction, GTPase-Activating Proteins, ras GTPase-Activating Proteins, Neurofibromin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review